HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

This year's cohort of new issues are rallying on their first day of trading, which bodes well for IPOs to come.

Alluvial Capital Management, an investment advisory firm, released its second-quarter 2025 investor letter. A copy of the same can be downloaded here. The fund rose 8.5% in the quarter, bringing the ...

The company will use the funds to open a new headquarters in the Bay Area, scale its reach and platform, and expand its ...